These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 1488869)

  • 41. Chronic granulocytic leukemia in blastic crisis. Prognostic factors.
    Sales V; Rojo J; Collazo J; Lagunas E; Aguilar E; Albisua L
    In Vivo; 1991; 5(3):281-5. PubMed ID: 1893082
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Blastic phase of chronic myelogenous leukemia.
    Morris EL; Dutcher JP
    Clin Adv Hematol Oncol; 2005 Jul; 3(7):547-52. PubMed ID: 16167037
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Blast crisis of chronic myelogenous leukemia in long-lasting systemic lupus erythematosus: regression of both diseases after autologous bone marrow transplantation.
    Meloni G; Capria S; Vignetti M; Mandelli F; Modena V
    Blood; 1997 Jun; 89(12):4659. PubMed ID: 9192793
    [No Abstract]   [Full Text] [Related]  

  • 44. A Case of Childhood Blastic Phase Chronic Myeloid Leukemia With Minor BCR-ABL.
    Yamanaka J; Shimizu M; Sato M; Inoue M; Matsui M; Shimada H; Shichino H
    J Pediatr Hematol Oncol; 2020 Aug; 42(6):e459-e462. PubMed ID: 30994506
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Percentage of Philadelphia chromosome (Ph)-negative and Ph-positive cells found after autologous transplantation for chronic myelogenous leukemia depends on percentage of diploid cells induced by conventional-dose chemotherapy before collection of autologous cells.
    Talpaz M; Kantarjian H; Liang J; Calvert L; Hamer J; Tibbits P; Durett A; Claxton D; Giralt S; Khouri I
    Blood; 1995 Jun; 85(11):3257-63. PubMed ID: 7756658
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Complete cytogenetic and molecular remission in a case of lymphoid blast crisis in chronic myeloid leukemia with intensive chemotherapy and interferon alpha.
    Fabbiano F; Santoro A; Di Trapani F; Marino MA; Pampinella M; Caronia F
    Eur J Haematol; 1993 Aug; 51(2):122-3. PubMed ID: 8370420
    [No Abstract]   [Full Text] [Related]  

  • 47. Extramedullary relapse of chronic myeloid leukemia in blast crisis: more questions than answers.
    Ross DM
    Leuk Lymphoma; 2009 Apr; 50(4):517-8. PubMed ID: 19373644
    [No Abstract]   [Full Text] [Related]  

  • 48. The biology of chronic myelogenous leukemia progression: who, what, where, and why?
    Radich JP
    Hematol Oncol Clin North Am; 2011 Oct; 25(5):967-80, v. PubMed ID: 22054729
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tetrasomy of Philadelphia chromosome in myeloblastic crisis of chronic myelogenous leukemia.
    Oikawa H; Utsugisawa T; Murai K; Narigasawa Y; Miyairi Y; Shimosegawa K; Suzuki T; Kuriya S
    Int J Hematol; 1995 Jun; 61(4):229-30. PubMed ID: 8547613
    [No Abstract]   [Full Text] [Related]  

  • 50. Chronic myeloid leukaemia with massive lymphadenopathy.
    Sundar S; Singh VP
    J Assoc Physicians India; 1992 Apr; 40(4):285. PubMed ID: 1452552
    [No Abstract]   [Full Text] [Related]  

  • 51. Successful treatment of accelerated and blastic phase of chronic myeloid leukemia with high-dose interferon alpha and hydroxyurea: a novel approach.
    Jehn U; Pötscher C; Heinemann V
    Leuk Lymphoma; 1995 Sep; 19(1-2):153-7. PubMed ID: 8574162
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Blastic phase of chronic myeloid leukemia (blCML): a proposal for standardization of diagnostic and response criteria.
    Arlin ZA; Silver RT; Bennett JM
    Leukemia; 1990 Nov; 4(11):755-7. PubMed ID: 2232887
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential depth of treatment response required for optimal outcome in patients with blast phase versus chronic phase of chronic myeloid leukemia.
    Chen Z; Medeiros LJ; Kantajian HM; Zheng L; Gong Z; Patel KP; Xiong H; Wang W; Cortes JE; Hu S
    Blood Cancer J; 2017 Feb; 7(2):e521. PubMed ID: 28157214
    [No Abstract]   [Full Text] [Related]  

  • 54. Extramedullary blast crisis in a patient with Philadelphia chromosome-positive chronic myelogenous leukemia in complete cytogenetic remission.
    O'Brien S; Witt R; Talpaz M; Kantarjian H
    Cancer; 1991 Apr; 67(7):1946-9. PubMed ID: 2004308
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Induction of molecular remission by donor peripheral blood leukocyte therapy in patients relapsing with extramedullary blastic phase chronic myeloid leukemia after allogeneic bone marrow transplantation.
    Bashey A; Shepherd S; Frankel W; Wang-Rodriguez J; Cahill T; Chamberlain M; Mason JR; Ho AD; Corringham RE
    Oncol Rep; 1998; 5(1):281-5. PubMed ID: 9458334
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinical study of chronic myelogenous leukemia].
    Shibata A
    Nihon Naika Gakkai Zasshi; 1993 Sep; 82(9):1318-30. PubMed ID: 8245626
    [No Abstract]   [Full Text] [Related]  

  • 57. [Clinical morphology of chronic myeloid leukemia].
    Khokhlova MP; Semenova EA
    Arkh Patol; 1992; 54(4):20-4. PubMed ID: 1444850
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Clinical manifestations and staging system].
    Jinnai I
    Nihon Rinsho; 2001 Dec; 59(12):2311-5. PubMed ID: 11766331
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Extramedullary blast crisis in chronic myeloid leukemia.
    Specchia G; Palumbo G; Pastore D; Mininni D; Mestice A; Liso V
    Leuk Res; 1996; 20(11-12):905-8. PubMed ID: 9009247
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Early lymphoid blastic crisis following major karyotypic conversion in a chronic myeloid leukemia patient treated with interferon-alpha.
    Ambrosetti A; Krampera M; Veneri D; Meneghini V; Aprili F; Martinelli G; Pizzolo G; Perona G
    Int J Clin Lab Res; 1994; 24(1):58-9. PubMed ID: 8180425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.